Resources > Publications

Publications

Our employees in the spotlight.

Interview with David Beyerlein on Multi-site Validation and 8th WRIB

Gregory Reynolds, David Beyerlein, Bruce Babson • MicroConstants, Inc., San Diego, CA Prabhavathi Fernandes, Amanda Sheets • Cempra Pharmaceuticals, Chapel Hill, NC Presented at the 8th Workshop on Recent Issues in Bioanalysis (WRIB), Los Angeles, CA, March 2014

Our VP of Global Operations, David Beyerlein, spoke with Bioanalysis Zone regarding multi-site validation to safely remove anthrax spores from study samples as presented in a poster at the 8th annual Workshop on Recent Issues in Bioanalysis (WRIB).  View the poster David is discussing in the interview

interview-with-david-beyerlein-on-multi-site-validation-and-8th-wrib

C-Ring Cannabinoid Lactones: A Novel Cannabinergic Chemotype.

ACS Medicinal Chemistry Letters, January 2014

One of our DMPK scientists, Rishi Sharma, Ph.D., co-authored a paper on C-Ring Cannabinoid Lactones: A Novel Cannabinergic Chemotype which was published in the ACS Medicinal Chemistry Letters. The paper was a result of his graduate research at Northeastern University.  Read this publication

c-ring-cannabinoid-lactones-a-novel-cannabinergic-chemotype

Maternal Administration of Solithromycin, a New, Potent, Broad-Spectrum Fluoroketolide Antibiotic, Achieves Fetal and Intraamniotic Antimicrobial Protection In a Pregnant Sheep Model

Journal of Antimicrobial Agents and Chemotherapy, November 2013

One of our sponsors, Cempra Pharmaceuticals, successfully demonstrated the ability of their antibiotic, solithromycin, to cross the maternal/fetal barrier in a pregnant sheep model. MicroConstants provided the analytical support for this study and David Johnson, Ph.D., our Director of DMPK, contributed to a paper that was published on the story in the December issue of the Journal of Antimicrobial Agents and Chemotherapy.  Read this paper

maternal-administration-of-solithromycin-a-new-potent-broad-spectrum-fluoroketolide-antibiotic-achieves-fetal-and-intraamniotic-antimicrobial-protection-in-a-pregnant-sheep-model

Controlled-Deactivation Cannabinergic Ligands

Journal of Medicinal Chemistry, November 2013

One of our DMPK scientists, Rishi Sharma, Ph.D., co-authored a paper on Controlled- Deactivation Cannabinergic Ligands which was published in the Journal of Medicinal Chemistry. The paper was a result of his graduate research at Northeastern University.  Read this publication

controlled-deactivation-cannabinergic-ligands

Ask the Experts: Outsourcing in a Bioanalytical Laboratory

Bioanalysis, October 2013

David Beyerlein, our Vice President of Global Operations, was interviewed for the Ask the Experts: Outsourcing in a Bioanalytical Laboratory article which appeared in the October issue of Bioanalysis. The Journal invited a selection of leading researchers to express their views on outsourcing bioanalysis, including ways to effectively manage costs while maintaining productivity and quality of work. Their responses provide valuable insight into the impact of outsourcing and the future of the constantly evolving bioanalytical laboratory.  Read this article

ask-the-experts-outsourcing-in-a-bioanalytical-laboratory

Perspective On: A Contract Research Lab

Lab Manager Magazine, March 2012

David Beyerlein, our Vice President of Global Operations, was interviewed by Lab Manager Magazine for their March issue. Read the article to get our perspective on running a bioanalytical CRO, including our inventory management and maintenance procedures, communication policies, and some of the challenges we have faced.  Read this article

perspective-on-a-contract-research-lab

Ready to Start Your Project? Have a Question?

Our scientists are available to discuss how our bioanalytical CRO can help you streamline the drug development process through specialized expertise in regulated bioanalysis, DMPK, and pharmacokinetic analysis.

  • This field is for validation purposes and should be left unchanged.